SA
SAB Biotherapeutics, Inc.
SABSW · NASDAQ
$0.02 -0.55% (-$0.00)
1M -7.14%
Market Cap $174.0K
P/E Ratio -
Div. Yield -
ROE 6.74%
Bulios Fair Price
$0.03
64.8% upside
Trenutna cena
$0.018
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica SABSW trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
2/9Valuation
100 /100
Cheap P/B 0.00x
PEG N/A
P/E N/A
Growth
100 /100
Growing Book val. growth 69.59%
FCF growth N/A
EPS growth N/A
Profitability
-
N/A Op. margin N/A
Gross margin N/A
FCF margin N/A
Quality
0 /100
Poor ROA 5.36%
ROIC 31.62%
Asset turnover 0.00x
Debt
69 /100
Low Int. coverage -54.18x
Debt/Equity 0.02x
Current ratio 9.22x
Stability
32 /100
Unstable EPS volatility 83.32%
Beta 0.53x
Profitable years 1
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o SABSW
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Samuel J. Reich
Employees
86
Headquarters
Miami Beach
Prihajajoči dogodki
17 NOV.
Earnings
Upcoming earnings report